| Mar'19 | Dec'17 | Dec'16 | Dec'15 | |||
|---|---|---|---|---|---|---|
License revenues | ||||||
7,724 | - | - | - | |||
Operating expenses: | ||||||
Research and development | ||||||
3,929 | 4,438 | 673 | 1,620 | |||
General and administrative | ||||||
6,852 | 6,629 | 1,039 | 589 | |||
Costs related to aborted IPO | ||||||
- | - | 621 | - | |||
Costs related to aborted IPO | ||||||
- | - | - | 0 | |||
Operating loss | ||||||
-3,058 | -11,067 | -2,333 | -2,209 | |||
Other income (loss) | ||||||
Change in fair value of warrant liabilities | ||||||
- | -5,411 | - | - | |||
Realized and unrealized loss on available for sale marketable securities | ||||||
-3,581 | - | - | - | |||
Dividend income | ||||||
85 | - | - | - | |||
Amortization of beneficial conversion feature and debt issuance costs related to convertible note | ||||||
- | 1,031 | - | - | |||
Issuance cost related to warrants to investors and placement agent | ||||||
- | -457 | - | - | |||
Imputed interest with respect to convertible notes | ||||||
- | 14 | - | - | |||
Amortization of debt issuance cost | ||||||
- | 14 | - | - | |||
Foreign exchange gain | ||||||
-0 | - | - | - | |||
Issuance of common stock to finder fee upon the conversion of convertible notes | ||||||
- | -18 | - | - | |||
Other income (expenses) | ||||||
-3 | -29 | - | - | |||
Financial expenses, net | ||||||
- | - | -1,360 | - | |||
Total other income (loss) | ||||||
-3,499 | -6,976 | - | -994 | |||
Revaluation of warrants to purchase Convertible Preferred A Shares | ||||||
- | - | - | -152 | |||
Loss before taxes on income | ||||||
- | - | -3,693 | -3,355 | |||
Provision for income taxes | ||||||
- | - | 27 | 127 | |||
Net loss attributed to common shareholders | ||||||
-6,558 | -18,044 | -3,720 | -3,482 | |||
Unrealized gain on marketable securities | ||||||
- | 2 | - | - | |||
Net unrealized gain on available-for-sale investments | ||||||
- | - | 0 | - | |||
Total other comprehensive loss | ||||||
-6,558 | -18,042 | -3,720 | - | |||
Net (loss) income (loss) per share - basic | ||||||
-0.77 | -3.01 | -2.69 | - | |||
Net (loss) income per share - diluted | ||||||
-0.77 | -3.01 | -2.69 | - | |||
Net basic and diluted loss per share | ||||||
- | - | 0.00 | -2.53 | |||
Weighted average number of common shares outstanding - basic | ||||||
8,498 | 6,002 | 1,448 | - | |||
Weighted average number of common shares outstanding - diluted | ||||||
8,498 | 6,002 | 1,448 | - | |||
Weighted average number of shares of common stock used in computing basic and diluted net loss per share | ||||||
- | - | 0 | 1,448 | |||